Trial Profile
OPEN CLINICAL TRIAL, MULTICENTER, WITH SUBCUTANEOUS IMMUNOTHERAPY IN DEPOT PRESENTATION, IN PATIENTS WITH ALLERGY RHINOCONJUNCTIVITIS SENSITIZED TO PARIETARIA JUDAICA [ENSAYO CLÍNICO ABIERTO, MULTICÁNTRICO CON INMUNOTERAPIA SUBCUTÁNEA EN PRESENTACION DEPOT EN PACIENTES CON RINOCONJUNTIVITIS ALÁRGICAS ENSIBILIZADOS A PARIETARIA JUDAICA]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2018
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors Bial
- 29 Aug 2018 Planned number of patients changed from 48 to 52.
- 06 May 2016 Status changed from recruiting to completed.
- 28 Jul 2015 New trial record